Yoshihisa Shimada

12PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersNatural language processingProcess control and simulationCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Personalized Prediction of Postoperative Recurrence in Lung Squamous Cell Carcinoma: Integrating AI-Based Nuclear Morphometry and Clinical Data.

|Dec 30, 2025
Prediction of Lymphovascular Invasion in Early-Stage Lung Adenocarcinoma Using Artificial Intelligence-Based Radiomics.

Yoshihisa Shimada, Kazuharu Harada, Yujin Kudo

|Aug 28, 2025
Early major adverse kidney events after lung transplantation: risk of chronic kidney disease and prognostic impact.

Yoshihisa Shimada, Chihiro Konoeda, Yue Cong

|Jun 10, 2025
Prognosis, imaging characteristics, and clinicopathological features of heavy smokers with clinical stage I lung adenocarcinoma: a multicenter study.

Ikki Takada, Yoshihisa Shimada, Takahiro Mimae

|Mar 22, 2025
Accuracy of artificial intelligence-based simulation for assessing lung vessels and volume using unenhanced computed tomography.

Kentaro Fukuta, Yoshihisa Shimada, Yuki Nagamatu

|Oct 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY).

Keiju Aokage, Shohei Koyama, Shogo Kumagai

Pageof 2

Frequent Collaborators

3 joint publications

Yujin Kudo

3 joint publications

Tomohiro Miyoshi

2 joint publications

Keiju Aokage

2 joint publications

Kenji Suzuki